FBXW7 and metabolic dysfunction-associated steatotic liver disease: Previous studies suggest that FBXW7 is down-regulated in NAFLD mouse models and patients (Tu et al. 2012; Zhao et al. 2018), indicating a regulatory role of FBXW7 in the development of NAFLD.